首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Expression and secretion of neuregulin-1 in cardiac microvascular endothelial cells treated with angiogenic factors
【2h】

Expression and secretion of neuregulin-1 in cardiac microvascular endothelial cells treated with angiogenic factors

机译:神经调节素-1在血管生成因子处理的心脏微血管内皮细胞中的表达和分泌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Neuregulin-1 (NRG-1) is a positive regulator of angiogenesis, which suggests there may be an association between NRG-1 and angiogenic factors. The aim of the present study was to investigate the effect of treating human cardiac microvascular endothelial cells (HCMECs) with angiogenic factors on NRG-1 expression and secretion. HCMECs were cultured and stimulated with vascular endothelial growth factor (VEGF; 100 ng/ml), angiopoietin (Ang)-1 (100 ng/ml) or Ang-2 (100 ng/ml) under normal or hypoxia/serum deprivation (Hypo/SD) conditions for 24 h. The expression of ErbB receptors and NRG-1 in HCMECs was measured by western blot analysis and the secretion of NRG-1 in HCMECs was determined by ELISA. The results demonstrated that ErbB2, ErbB3 and ErbB4 were expressed in HCMECs and that ErbB2 expression levels were notably higher than those of ErbB3 and ErbB4. Under normal culture conditions the expression and secretion of NRG-1 was significantly increased in HCMECs treated with VEGF or Ang-1 (P<0.05), however levels significantly decreased in HCMECs treated with Ang-2 (P<0.05). Under Hypo/SD conditions the expression and secretion of NRG-1 significantly increased (P<0.05) and VEGF or Ang-1 treatment significantly increased these effects further (P<0.05). Conversely Ang-2 treatment significantly decreased these effects (P<0.05). The expression and release of NRG-1 were significantly increased in HCMECs with VEGF or Ang-1 treatment (P<0.05), which suggests that VEGF and Ang-1 may regulate myocardial angiogenesis and survival via the NRG-1/ErbB signaling pathway.
机译:Neuregulin-1(NRG-1)是血管生成的正向调节剂,这表明NRG-1与血管生成因子之间可能存在关联。本研究的目的是研究用血管生成因子治疗人心脏微血管内皮细胞(HCMEC)对NRG-1表达和分泌的影响。培养HCMECs并在正常或缺氧/血清剥夺(Hypo)下用血管内皮生长因子(VEGF; 100 ng / ml),血管生成素(Ang)-1(100 ng / ml)或Ang-2(100 ng / ml)刺激/ SD)条件,持续24小时。通过Western blot分析检测HCMECs中ErbB受体和NRG-1的表达,并通过ELISA检测NCM-1在HCMECs中的分泌。结果表明ErbB2,ErbB3和ErbB4在HCMEC中表达,并且ErbB2表达水平明显高于ErbB3和ErbB4。在正常培养条件下,用VEGF或Ang-1处理的HCMECs中NRG-1的表达和分泌显着增加(P <0.05),但是用Ang-2处理的HCMECs中NRG-1的表达和分泌显着降低(P <0.05)。在Hypo / SD条件下,NRG-1的表达和分泌显着增加(P <0.05),而VEGF或Ang-1处理则显着增加了这些作用(P <0.05)。相反,Ang-2治疗显着降低了这些作用(P <0.05)。 NCM-1的表达和释放在接受VEGF或Ang-1治疗的HCMEC中显着增加(P <0.05),这表明VEGF和Ang-1可能通过NRG-1 / ErbB信号通路调节心肌血管生成和存活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号